NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia

Clinical trial NCT04315987 · COMPLETED

Trial details

NCT number: NCT04315987
Sponsor: Azidus Brasil
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2020-06-30
Primary completion: 2021-02-28
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.